0IL8.LKyntra Bio, Inc.

Acerca de

Kyntra Bio, Inc. is a biopharmaceutical enterprise focused on the entire spectrum of therapeutic innovation, from discovering new compounds to developing and commercializing them. Leveraging profound insights into hypoxia-inducible factor (HIF) and connective tissue growth factor (CTGF) biology, the company strives to engineer effective medicinal solutions for anemia, fibrotic conditions, and various forms of cancer. Founded by Thomas B. Neff on September 29, 1993, Kyntra Bio, Inc. maintains its corporate headquarters in San Francisco, California.

www.kyntrabio.com

Estadísticas clave

Cap. de mercado

30.30M

BPA

45.36

Rend. dividendo

0.00%

Beta

0.99

P/VC

-1.17

ROE

-435.8%

Sector

Healthcare

Industria

Medical - Pharmaceuticals

CEO

Thane Wettig

Empleados

225

Fecha IPO

2018-01-29

País

US